When the FDA demands a new standard of balance in how benefits and risks are communicated, it should be framed against the larger backdrop of what harms Americans every day.

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.

A study links lower levels of the inhibitory neurotransmitter GABA to neuropathic pain in people with HIV, offering insight into potential pain mechanisms.

This article was reviewed by Kelly Brown MD, MBA. Like other medications that affect your hormones, taking testosterone comes ...

The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage® FLX, Clear + Brilliant®, and Fraxel FTX™ offer energy-based treatment options that help maintain a youthful appea ...